drugset / Trial / NCT02374164

Food Effect Study of Febuxostat XR in Healthy Participants

NCT02374164

Phase 1 Completed 36 enrolled Takeda
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to assess the effect of food on the bioavailability of febuxostat after a single oral dose of 80 mg febuxostat XR and to evaluate the pharmacokinetics (PK) of febuxostat after single oral doses of 40 and 80 mg febuxostat XR.

Timeline

Start
2015-02
Primary completion
2015-03
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Febuxostat Small molecule 40 mg Oral
Subject Febuxostat Small molecule 80 mg Oral

Indications